Effect of iron supplementation on incidence of infectious illness in children: systematic review.
OBJECTIVE
To evaluate the effect of iron supplementation on the incidence of infections in children.


METHODS
Systematic review of randomised controlled trials.


METHODS
28 randomised controlled trials (six unpublished and 22 published) on 7892 children.


METHODS
Oral or parenteral iron supplementation or fortified formula milk or cereals.


RESULTS
Incidence of all recorded infectious illnesses, and individual illnesses, including respiratory tract infection, diarrhoea, malaria, other infections, and prevalence of positive smear results for malaria.


RESULTS
The pooled estimate (random effects model) of the incidence rate ratio (iron v placebo) was 1.02 (95% confidence interval 0.96 to 1.08, P=0.54; P<0.0001 for heterogeneity). The incidence rate difference (iron minus placebo) for all recorded illnesses was 0.06 episodes/child year (-0.06 to 0.18, P=0.34; P<0.0001 for heterogeneity). However, there was an increase in the risk of developing diarrhoea (incidence rate ratio 1.11, 1.01 to 1.23, P=0.04), but this would not have an overall important on public health (incidence rate difference 0.05 episodes/child year, -0.03 to 0.13; P=0.21). The occurrence of other illnesses and positive results on malaria smears (adjusted for positive smears at baseline) were not significantly affected by iron administration. On meta-regression, the statistical heterogeneity could not be explained by the variables studied.


CONCLUSIONS
Iron supplementation has no apparent harmful effect on the overall incidence of infectious illnesses in children, though it slightly increases the risk of developing diarrhoea.
Gera
Tarun
T
Division of Clinical Epidemiology, Department of Paediatrics, Maulana Azad Medical College, New Delhi 110002, India.
Sachdev
H P S
HP
D018798:Anemia, Iron-Deficiency / Q000517:prevention & control*; D002648:Child; D016001:Confidence Intervals; D003967:Diarrhea / Q000209:etiology; D019587:Dietary Supplements / Q000009:adverse effects; D006801:Humans; D007239:Infections / Q000209:etiology*; D007501:Iron / Q000008:administration & dosage / Q000009:adverse effects*; D000090463:Iron Deficiencies; D008288:Malaria / Q000209:etiology; D012044:Regression Analysis; D012307:Risk Factors
D007501:Iron